The 74 reports on 11 AI prompts that can assist teachers in streamlining tasks and enhancing creativity, helping to improve their work-life balance and effectiveness.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

A Merck KGaA, Darmstadt, Germany, researcher at work. Merck KGaA has agreed to acquire Bio-Techne for approximately $11.3 billion, in a deal designed to position the buyer as more of a leader across ...

A German company that provides products and services that accelerate drug development and manufacturing is set to acquire the Minneapolis-based group Bio-Techne, according to a news release posted ...

Germany’s Merck MRK0.07%increase; up pointing triangle KGaA said it struck a deal to buy U.S. life-sciences tools supplier Bio-Techne TECH 0.21%increase; up pointing triangle for $11.3 billion, in an ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The deal represents a 36% ...

Merck KGaA agreed to buy Bio-Techne Corporation for about $11.3 billion to bolster its life-science business, marking the German pharma and technology group’s biggest acquisition in more than a decade ...

German drugmaker Merck KGaA said on Thursday it will acquire U.S. biotech firm Bio-Techne for $11.3 billion, its largest deal in over a decade, as it looks to strengthen its life sciences business.

Merck offered $73 per share, implying a 24% premium to Wednesday's close Merck expects deal to close by late 2026 or early 2027 Sees about 140 million euros in cost savings by the third year after ...

With Merck KGaA’s former electronics business lead Kai Beckmann now at the helm of the entire conglomerate, the new CEO is making his mark with a major outlay to support the company’s life sciences ...

Germany’s Merck KGaA will buy Bio-Techne Corp. in a deal worth $11.3 billion, one of the largest acquisitions in Minnesota history. The sale follows investor pressure on Minneapolis-based Bio-Techne, ...

June 25 (Reuters) - German ⁠drugmaker ⁠Merck KGaA said on Thursday it would ⁠buy U.S. firm Bio-Techne for $11.3 billion, its biggest deal in more than a decade, betting on demand for complex drug ...